SCHEMBL18201304

SCHEMBL18201304

c1ccc(-c2cccc(-c3ccc(-c4cc5c(-c6ccc7ccccc7c6)nc6ccccc6c5c5ccccc45)cc3)n2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.39
▸ LMNA P02545 3/20 0.39
▸ TP53 P04637 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ ALPL P05186 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ ALPI P09923 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ CCR1 P32246 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CCR5 P51681 1/20 0.39
▸ CCR8 P51685 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200682 0.94 SIRT2 (0.38) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18201208 0.94 CYP2C9 (0.38) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18200640 0.93 SIRT2 (0.38) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18201036 0.93 DHODH (0.44) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18200777 0.91 CYP2C9 (0.41) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18201143 0.90 DHODH (0.46) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18201307 0.90 CYP2C9 (0.39) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18201302 0.89 KDM4E (0.46) DHODHKDM4ELMNASMN1; SMN2MAPK1
SCHEMBL18201202 0.89 CYP2C9 (0.39) DHODHKDM4ELMNATP53SMN1; SMN2
SCHEMBL18200631 0.89 CYP2C9 (0.39) DHODHKDM4ELMNATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 — — US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 DHODH 33/4885KDM4E 1977/4885LMNA 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback